gyki 52466 has been researched along with Central Nervous System Diseases in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogawski, MA | 1 |
1 review available for gyki 52466 and Central Nervous System Diseases
| Article | Year |
|---|---|
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anticonvulsa | 1993 |